52 related articles for article (PubMed ID: 36151009)
21. Radioiodine therapy in the different stages of differentiated thyroid cancer.
Valerio L; Maino F; Castagna MG; Pacini F
Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101703. PubMed ID: 36151009
[TBL] [Abstract][Full Text] [Related]
22. Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer.
Juweid ME; Tulchinsky M; Mismar A; Momani M; Zayed AA; Al Hawari H; Albsoul N; Mottaghy FM
Int J Cancer; 2020 Nov; 147(9):2345-2354. PubMed ID: 32319676
[TBL] [Abstract][Full Text] [Related]
23. The evolving use of radioiodine therapy in differentiated thyroid cancer.
Mayson SE; Yoo DC; Gopalakrishnan G
Oncology; 2015; 88(4):247-56. PubMed ID: 25503797
[TBL] [Abstract][Full Text] [Related]
24. The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.
Rivkees SA; Mazzaferri EL; Verburg FA; Reiners C; Luster M; Breuer CK; Dinauer CA; Udelsman R
Endocr Rev; 2011 Dec; 32(6):798-826. PubMed ID: 21880704
[TBL] [Abstract][Full Text] [Related]
25. [Postoperative radioiodine ablation in patients with low risk differentiated thyroid carcinoma].
Díez JJ; Grande E; Iglesias P
Med Clin (Barc); 2015 Jan; 144(1):35-41. PubMed ID: 24613061
[TBL] [Abstract][Full Text] [Related]
26. An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer.
Sawka AM; Brierley JD; Tsang RW; Thabane L; Rotstein L; Gafni A; Straus S; Goldstein DP
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):457-80, x. PubMed ID: 18502337
[TBL] [Abstract][Full Text] [Related]
27. Radioactive Iodine for Papillary Thyroid Carcinoma.
Chan WWL; Kwong DLW
Methods Mol Biol; 2022; 2534():225-241. PubMed ID: 35670979
[TBL] [Abstract][Full Text] [Related]
28. Surgical options for thyroid cancer and post-surgical management.
Doubleday A; Sippel RS
Expert Rev Endocrinol Metab; 2018 May; 13(3):137-148. PubMed ID: 30058897
[TBL] [Abstract][Full Text] [Related]
29. Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer.
Sawka AM; Thephamongkhol K; Brouwers M; Thabane L; Browman G; Gerstein HC
J Clin Endocrinol Metab; 2004 Aug; 89(8):3668-76. PubMed ID: 15292285
[TBL] [Abstract][Full Text] [Related]
30. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
31. [Radioiodine therapy in differentiated thyroid gland carcinoma].
Schicha H; Dietlein M
Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
[TBL] [Abstract][Full Text] [Related]
32. Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions.
Mazzaferri EL; Kloos RT
Thyroid; 2000 Sep; 10(9):767-78. PubMed ID: 11041454
[TBL] [Abstract][Full Text] [Related]
33. Management of low-risk differentiated thyroid cancer.
Mazzaferri EL
Endocr Pract; 2007 Sep; 13(5):498-512. PubMed ID: 17872353
[TBL] [Abstract][Full Text] [Related]
34. Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update.
Ciarallo A; Rivera J
AJR Am J Roentgenol; 2020 Aug; 215(2):285-291. PubMed ID: 32551904
[No Abstract] [Full Text] [Related]
35. Current practice in intermediate risk differentiated thyroid cancer - a review.
do Prado Padovani R; Duarte FB; Nascimento C
Rev Endocr Metab Disord; 2024 Feb; 25(1):95-108. PubMed ID: 37995023
[TBL] [Abstract][Full Text] [Related]
36. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
37. Dynamic risk assessment in patients with differentiated thyroid cancer.
Pitoia F; Jerkovich F
Endocr Relat Cancer; 2019 Oct; 26(10):R553-R566. PubMed ID: 31394499
[TBL] [Abstract][Full Text] [Related]
38. Drug therapy alternatives in the treatment of thyroid cancer.
O'Doherty MJ; Coakley AJ
Drugs; 1998 Jun; 55(6):801-12. PubMed ID: 9617595
[TBL] [Abstract][Full Text] [Related]
39. The role of radioactive iodine in the management of patients with differentiated thyroid cancer - An oncologic surgical perspective.
Nixon IJ; Shah JP; Zafereo M; Simo RS; Hay ID; Suárez C; Zbären P; Rinaldo A; Sanabria A; Silver C; Mäkitie A; Vander Poorten V; Kowalski LP; Shaha AR; Randolph GW; Ferlito A
Eur J Surg Oncol; 2020 May; 46(5):754-762. PubMed ID: 31952928
[TBL] [Abstract][Full Text] [Related]
40. Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros.
Ain KB
Endocrine; 2015 Sep; 50(1):61-6. PubMed ID: 26109472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
